<--- Back to Details
First PageDocument Content
Chemistry / Non-small-cell lung carcinoma / Protein kinase inhibitor / Cancer / AP26113 / Targeted therapy of lung cancer / Medicine / Lung cancer / Oncology
Date: 2015-04-21 14:44:56
Chemistry
Non-small-cell lung carcinoma
Protein kinase inhibitor
Cancer
AP26113
Targeted therapy of lung cancer
Medicine
Lung cancer
Oncology

Add to Reading List

Source URL: us.boehringer-ingelheim.com

Download Document from Source Website

File Size: 116,49 KB

Share Document on Facebook

Similar Documents

Chemistry / Non-small-cell lung carcinoma / Protein kinase inhibitor / Cancer / AP26113 / Targeted therapy of lung cancer / Medicine / Lung cancer / Oncology

PDF Document

DocID: 14LKt - View Document

Biology / Cancer / Targeted therapy / College of American Pathologists / Combined small-cell lung carcinoma / AP26113 / Medicine / Lung cancer / Pathology

Microsoft Word - 20150112_LBG-REV_PressRelease

DocID: XI3l - View Document

Alkynes / Amines / Piperazines / Organochlorides / AP26113 / Gefitinib / Erlotinib / Crizotinib / Non-small-cell lung carcinoma / Chemistry / Organic chemistry / Organofluorides

November 2012  Volume 16, Issue 9        The investment report that gives you the essenƟals to wisely invest in biotechnology securiƟes.

DocID: XuxZ - View Document

ALK inhibitor / Anaplastic lymphoma kinase / Crizotinib / Non-small-cell lung carcinoma / Cancer / Metastasis / EML4-ALK positive lung cancer / AP26113 / Medicine / Lung cancer / Organofluorides

ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium

DocID: R4Ac - View Document

Epidermal growth factor receptor / Oncogenes / Immune system / Kupffer cell / Cancer research / Targeted therapy / Austrian Science Fund / Gefitinib / AP26113 / Biology / Medicine / Macrophages

Precisely Off The Mark: Possible Cause Discovered For Failure of Targeted Liver Cancer Therapies Date: [removed]:29 PM CET Category: Health & Medicine Press release from: FWF - Austrian Science Fund Agency: PR&D

DocID: R0qo - View Document